Study S000236

Is the Stepping-down Approach a Better Option Than Multiple Daily Injections in Patients With Chronic Poorly-controlled Diabetes on Advanced Insulin Therapy?

Included trial: extracted data ClinicalTrials.gov record Study Protocol and Statistical Analysis Plan (PDF)

Registration

Registration: NCT02846233
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Masking: NONE
Status: COMPLETED
Enrollment: 22
Start: 2016-08
Primary completion: 2018-12
Lead sponsor: University of California, San Francisco
Conditions: Type 2 Diabetes Mellitus
Interventions: DRUG:GLP1 receptor agonist; DRUG:basal insulin; DRUG:SGLT2 inhibitor; DRUG:Metformin
Results posted: TRUE
Individual participant data sharing: NO

Registered primary outcomes

Change in A1c at the End of Study Period [16 weeks (from baseline to end of study at 16 weeks)]

Linked records (2)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

Record	Title	Year	Design	Identifiers	Link basis
R0027861	SUN-LB115 Is the Stepping-Down Approach a Better Option Than Multiple Daily Injections in Patients With Chronic Poorly-Controlled Diabetes on Advanced Insulin Therapy? Naing S, Journal of the Endocrine Society	2020	Randomized trial	DOI	cites ClinicalTrials.gov:NCT02846233
R0016788	Glucagon-like peptide 1 receptor agonist or bolus insulin with optimized basal insulin in type 2 diabetes. Diamant M, Diabetes care	2014	Randomized trial	PMID 25011946 DOI	registry reference BACKGROUND:25011946